Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Mechanisms, strategies, and clinical application progress of subcutaneous transplantation angiogenesis

Li Y., Ye X., Chen S., Guo L., Xu Z., Chen J.

Narrative Review on Immune Modulation, Autoimmune Research, published in Front Bioeng Biotechnol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Bioeng Biotechnol (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41346468
PMCID
PMC12672506
DOI
10.3389/fbioe.2025.1665643

Abstract (original English)

Subcutaneous transplantation, as an important technology in cell and tissue engineering, has received considerable attention due to its simplicity of operation, strong reproducibility, and potential clinical application value. However, the limitations of the vascular network in subcutaneous tissue severely restrict the survival and functionality of transplanted cells; therefore, angiogenesis has become a key factor in improving the success rate of transplants. Currently, despite progress in the research of subcutaneous transplantation, there are still many challenges and shortcomings. This article reviews the molecular mechanisms of angiogenesis in subcutaneous transplantation, strategies involving cells and biomaterials, as well as the latest technological advancements in promoting angiogenesis. It focuses on analyzing research results in aspects such as growth factor delivery, co-transplantation of cells, scaffold material optimization, and immune regulation. At the same time, the article systematically summarizes the clinical application prospects and challenges of subcutaneous angiogenesis strategies in islet transplantation, soft tissue repair, and autoimmune diseases. By comprehensively analyzing the current research hotspots and difficulties, it aims to provide theoretical support and practical guidance for future basic research and clinical translation of angiogenesis i

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research